Status:

COMPLETED

Non-invasive Measurement of Brain Oxygen Levels in People With Subthalamic Deep Brain Stimulators

Lead Sponsor:

Beth Israel Deaconess Medical Center

Conditions:

Parkinson's Disease

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The purpose of this study is to determine if deep brain stimulation can change brain oxygen levels in people with Parkinson's Disease. Measurements will be taken using a non-invasive device while subj...

Detailed Description

The investigators will study the effects of electrical stimulation at the subthalamic nucleus on frontal cerebral perfusion in 10 patients with advanced PD who have already undergone successful STN DB...

Eligibility Criteria

Inclusion

  • Age 18-75
  • Diagnosis of Idiopathic Parkinson's disease made by a movement disorders neurologist.
  • At least 3 months status-post bilateral subthalamic deep brain stimulation surgery
  • Positive response to STN DBS as evidenced by \>20% improvement in UPDRS-III score after surgery as determined by a movement disorders neurologist.
  • Cognitively intact as demonstrated with a MOCA \> 24.
  • Signed informed consent.

Exclusion

  • Failure to meet all of the inclusion criteria.

Key Trial Info

Start Date :

October 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2015

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT02278406

Start Date

October 1 2014

End Date

September 1 2015

Last Update

May 8 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215